CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 15)

Average Co-Inventor Count = 7.9

ph-index = 15

Forward Citations = 521(Granted Patents)

Location History:

Newark, CA (US) (2008)
Pacific Palisades, CA (US) (2007 - 2017)
Santa Monica, CA (US) (2009 - 2018)
Los Angeles, CA (US) (2006 - 2023)

Company Filing History:

Seattle Genetics, Inc.

where one patent can have more than one assignee

Years Active: 2006-2023

Loading Chart...

Areas of Expertise:

Antibody Drug Conjugates

Epidermal Growth Factor Receptor

STEAP-1 Proteins

Nucleic Acid Molecules

Cancer Diagnosis

Monocyte Chemo-attractant Protein

Prostate Cancer Treatment

Carbonic Anhydrase IX

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11559582 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2023-01-24),

2. 11492411 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2022-11-08),

3. 11401347 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2022-08-02),

4. 11266745 - Extension sequences for diabodies (2022-03-08),

5. 11254744 - Antigen binding constructs to target molecules (2022-02-22),

6. 10894090 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2021-01-19),

7. RE48389 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2021-01-11),

8. 10597463 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2020-03-24),

9. 10508153 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2019-12-17),

10. 10118968 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2018-11-06),

11. 9962454 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2018-05-08),

12. 9617346 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2017-04-11),

13. 9314538 - Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2016-04-19),

14. 9308278 - Antibody drug conjugates (ADC) that bind to 161P2F10B proteins (2016-04-12),

15. 9096672 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2015-08-04),

Title: The Innovative Mind of Jean M Gudas

Introduction: Jean M Gudas, a talented inventor based in Santa Monica, CA, has made significant contributions to the world of technology and innovation.

Latest Patents: Jean M Gudas holds several patents in various fields, including telecommunications, renewable energy, and medical devices. His most recent patent involves a groundbreaking technology for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Jean M Gudas has worked for leading tech companies, where he spearheaded research and development projects that resulted in cutting-edge inventions. His innovative solutions have been recognized for their impact on improving efficiency and security in different industries.

Collaborations: Throughout his career, Jean M Gudas has collaborated with top engineers, scientists, and researchers to bring his ideas to life. His ability to work in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking technologies.

Conclusion: Jean M Gudas continues to push the boundaries of innovation, with a relentless drive to create solutions that address complex challenges in today's fast-paced world. His passion for invention and his dedication to making a positive impact make him a true pioneer in the field of technology.

This text is generated by artificial intelligence and may not be accurate.